...
首页> 外文期刊>Thrombosis Research: An International Journal on Vascular Obstruction, Hemorrhage and Hemostasis >Hyperhomocysteinemia and the presence of cardiovascular disease are associated with kynurenic acid levels and carotid atherosclerosis in patients undergoing continuous ambulatory peritoneal dialysis
【24h】

Hyperhomocysteinemia and the presence of cardiovascular disease are associated with kynurenic acid levels and carotid atherosclerosis in patients undergoing continuous ambulatory peritoneal dialysis

机译:高同型半胱氨酸血症和心血管疾病的存在与连续非卧床腹膜透析患者的尿酸水平和颈动脉粥样硬化有关

获取原文
获取原文并翻译 | 示例

摘要

Introduction: Hyperhomocysteinemia and the activation of kynurenine (KYN) pathway have been reported as the factors participated in atherosclerosis in uraemic patients. The objective of this study was to verify whether hyperhomocysteinemia may be involved in atherosclerotic cardiovascular disease (CVD) in patients undergoing continuous ambulatory peritoneal dialysis (CAPD). Materials and methods: We determined the plasma concentrations of KYN, KYNA, KYNA/KYN ratio, homocysteine (Hcy) and intima-media thickness (IMT) - an early reflection of the systemic atherosclerosis in CAPD patients both with and without CVD and healthy controls. Results: KYNA concentrations and KYNA/KYN ratio were about 3 times higher in the patients with hyperhomocysteinemia (Hcy > 15 μM) compared to those with normal Hcy levels (< 15 μM), and they were significantly lower in CVD[+] than in CVD[-] patients in these studied groups. The presence of CVD was associated with higher Hcy levels only in the patients with Hcy > 15 μM. The positive association was between Hcy and KYNA, KYNA/KYN ratio in all CAPD patients and in CVD[+] patients with hyperhomocysteinemia. IMT was positively associated with Hcy levels in patients with hyperhomocysteinemia, whereas there was no relationship between IMT and KYNA concentrations in the studied groups. Conclusions: These results showed the association between hyperhomocysteinemia and carotid atherosclerosis as well as the possible role of hyperhomocysteinemia in the activation of KYNA production in CAPD patients. The elevated KYNA levels observed in patients with hyperhomocysteinemia seem to be protective against Hcy-mediated atherosclerosis in these patients.
机译:简介:据报道,高同型半胱氨酸血症和犬尿氨酸(KYN)通路的激活是尿毒症患者参与动脉粥样硬化的因素。这项研究的目的是要验证正在进行连续非卧床腹膜透析(CAPD)的患者高同型半胱氨酸血症是否可能与动脉粥样硬化性心血管疾病(CVD)有关。材料和方法:我们确定了血浆KYN,KYNA,KYNA / KYN比,同型半胱氨酸(Hcy)和内膜中层厚度(IMT)的浓度-早期对患有和不患有CVD以及健康对照组的CAPD患者的全身动脉粥样硬化的反映。结果:高同型半胱氨酸血症(Hcy> 15μM)患者的KYNA浓度和KYNA / KYN比大约是正常Hcy水平(<15μM)患者的3倍,而CVD [+]则显着低于Hcy水平。这些研究组中的CVD [-]患者。仅在Hcy> 15μM的患者中,CVD的存在与较高的Hcy水平相关。在所有CAPD患者和高同型半胱氨酸血症的CVD [+]患者中,Hcy与KYNA,KYNA / KYN比之间呈正相关。高同型半胱氨酸血症患者中IMT与Hcy水平呈正相关,而研究组中IMT与KYNA浓度之间没有关系。结论:这些结果表明高同型半胱氨酸血症与颈动脉粥样硬化之间的关系,以及高同型半胱氨酸血症在CAPD患者KYNA产生激活中的可能作用。高同型半胱氨酸血症患者中观察到的KYNA水平升高似乎可以预防这些患者中Hcy介导的动脉粥样硬化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号